196 related articles for article (PubMed ID: 35101776)
41. Reversal of DNA damage induced Topoisomerase 2 DNA-protein crosslinks by Tdp2.
Schellenberg MJ; Perera L; Strom CN; Waters CA; Monian B; Appel CD; Vilas CK; Williams JG; Ramsden DA; Williams RS
Nucleic Acids Res; 2016 May; 44(8):3829-44. PubMed ID: 27060144
[TBL] [Abstract][Full Text] [Related]
42. Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae.
Pouliot JJ; Robertson CA; Nash HA
Genes Cells; 2001 Aug; 6(8):677-87. PubMed ID: 11532027
[TBL] [Abstract][Full Text] [Related]
43. Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panel.
Gao R; Das BB; Chatterjee R; Abaan OD; Agama K; Matuo R; Vinson C; Meltzer PS; Pommier Y
DNA Repair (Amst); 2014 Jan; 13():1-9. PubMed ID: 24355542
[TBL] [Abstract][Full Text] [Related]
44. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage.
Vance JR; Wilson TE
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13669-74. PubMed ID: 12368472
[TBL] [Abstract][Full Text] [Related]
45. Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.
Beretta GL; Cossa G; Gatti L; Zunino F; Perego P
Curr Med Chem; 2010; 17(15):1500-8. PubMed ID: 20166932
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer.
Hu DX; Tang WL; Zhang Y; Yang H; Wang W; Agama K; Pommier Y; An LK
J Med Chem; 2021 Jun; 64(11):7617-7629. PubMed ID: 34008967
[TBL] [Abstract][Full Text] [Related]
47. Tyrosyl-DNA phosphodiesterase (Tdp1) (3'-phosphotyrosyl DNA phosphodiesterase).
Raymond AC; Burgin AB
Methods Enzymol; 2006; 409():511-24. PubMed ID: 16793421
[TBL] [Abstract][Full Text] [Related]
48. Studying TDP1 Function in DNA Repair.
Chiang SC; Liversidge K; El-Khamisy SF
Methods Mol Biol; 2018; 1703():173-181. PubMed ID: 29177742
[TBL] [Abstract][Full Text] [Related]
49. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.
Dexheimer TS; Antony S; Marchand C; Pommier Y
Anticancer Agents Med Chem; 2008 May; 8(4):381-9. PubMed ID: 18473723
[TBL] [Abstract][Full Text] [Related]
50. Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel.
Maede Y; Shimizu H; Fukushima T; Kogame T; Nakamura T; Miki T; Takeda S; Pommier Y; Murai J
Mol Cancer Ther; 2014 Jan; 13(1):214-20. PubMed ID: 24130054
[TBL] [Abstract][Full Text] [Related]
51. Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA.
Morimoto S; Tsuda M; Bunch H; Sasanuma H; Austin C; Takeda S
Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31671674
[TBL] [Abstract][Full Text] [Related]
52. A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors.
Jakobsen AK; Keller JG; Gonzalez M; Martin-Encinas E; Palacios F; Alonso C; Knudsen BR; Stougaard M
Sensors (Basel); 2021 Jul; 21(14):. PubMed ID: 34300575
[TBL] [Abstract][Full Text] [Related]
53. TDP1-independent pathways in the process and repair of TOP1-induced DNA damage.
Zhang H; Xiong Y; Su D; Wang C; Srivastava M; Tang M; Feng X; Huang M; Chen Z; Chen J
Nat Commun; 2022 Jul; 13(1):4240. PubMed ID: 35869071
[TBL] [Abstract][Full Text] [Related]
54. Roles of eukaryotic topoisomerases in transcription, replication and genomic stability.
Pommier Y; Sun Y; Huang SN; Nitiss JL
Nat Rev Mol Cell Biol; 2016 Nov; 17(11):703-721. PubMed ID: 27649880
[TBL] [Abstract][Full Text] [Related]
55. Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes.
Miao ZH; Agama K; Sordet O; Povirk L; Kohn KW; Pommier Y
DNA Repair (Amst); 2006 Dec; 5(12):1489-94. PubMed ID: 16935573
[TBL] [Abstract][Full Text] [Related]
56. Transcriptomic Analysis of CRISPR/Cas9-Mediated PARP1-Knockout Cells under the Influence of Topotecan and TDP1 Inhibitor.
Dyrkheeva NS; Malakhova AA; Zakharenko AL; Okorokova LS; Shtokalo DN; Pavlova SV; Medvedev SP; Zakian SM; Nushtaeva AA; Tupikin AE; Kabilov MR; Khodyreva SN; Luzina OA; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982223
[TBL] [Abstract][Full Text] [Related]
57. Tyrosyl-DNA Phosphodiesterase I N-Terminal Domain Modifications and Interactions Regulate Cellular Function.
Brettrager EJ; Segura IA; van Waardenburg RCAM
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31698852
[TBL] [Abstract][Full Text] [Related]
58. TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts.
Fielden J; Wiseman K; Torrecilla I; Li S; Hume S; Chiang SC; Ruggiano A; Narayan Singh A; Freire R; Hassanieh S; Domingo E; Vendrell I; Fischer R; Kessler BM; Maughan TS; El-Khamisy SF; Ramadan K
Nat Commun; 2020 Mar; 11(1):1274. PubMed ID: 32152270
[TBL] [Abstract][Full Text] [Related]
59. Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase.
Debéthune L; Kohlhagen G; Grandas A; Pommier Y
Nucleic Acids Res; 2002 Mar; 30(5):1198-204. PubMed ID: 11861912
[TBL] [Abstract][Full Text] [Related]
60. DNA and RNA Cleavage Complexes and Repair Pathway for TOP3B RNA- and DNA-Protein Crosslinks.
Saha S; Sun Y; Huang SN; Baechler SA; Pongor LS; Agama K; Jo U; Zhang H; Tse-Dinh YC; Pommier Y
Cell Rep; 2020 Dec; 33(13):108569. PubMed ID: 33378676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
